Latest News

To investigate the predictive value of tumor infiltrating immune cells (TIICs) on oncological outcomes and response to BCG treatment in patients with Non-muscle invasive bladder cancer (NMIBC). A systematic review and meta-analysis was performed using the PubMed, Scopus, and Cochrane Library on July 2020 to identify relevant studies according to the Preferred Reporting Items for […]

Catheter-associated urinary tract infections (CAUTIs) are a major cause of harm in hospitalized children. While CAUTI prevention insertion and maintenance bundles have been developed, implemented, and validated in adult populations, their applicability to pediatric populations has been unclear because validation studies in children have been limited to small populations with a short duration of follow […]

Radical cystectomy is associated with some of the highest rates of morbidity and mortality in the field of urologic surgery. Despite this burden, there remains a lack of consensus as to when it is most useful to assess complications across the post-surgical recovery period. Our objective was to describe the time-course of major complications (Clavien […]

Tom Keane: Good afternoon, everybody. This is Tom Keane coming to you from UroToday. In these COVID times, it’s been a while since I’ve had an opportunity to address you, and today we have a real treat. Eric Rovner has been a member of the faculty at the Medical University of South Carolina for over 15 […]

Atlanta, Georgia (UroToday.com) Dr. Evan Yu from Seattle, Washington, gave his second talk of the day on “Optimizing the Use of Chemotherapy and Introducing Radiopharmaceuticals into Treatment Paradigm for Advanced Prostate Cancer” at the 2020 Prostate Cancer Academy.

Atlanta, Georgia (UroToday.com) Dr. Evan Yu from Seattle, Washington, presented on the “Evolving Role of Novel Hormonal Agents in Advanced Prostate Cancer” during the second day of the 2020 Prostate Cancer Academy.

In this work, we present recommendations to countries with limited health resources for management decisions in radiotherapy units during the pandemic for COVID-19. This effort aims to reduce the impact of the COVID-19 pandemic on the delivery of radiotherapy treatments. In countries like Ecuador, the access to radiotherapy for cancer patients is limited and this […]

Urothelial carcinoma (UC) is the most common histology of bladder cancer. Histological variants (HV) of bladder cancer are less common but frequently more aggressive. A recent paper published by Takemoto et al. in Anticancer Research studied the biological features and the prognostic value of HV in bladder cancer patients.

Atlanta, Georgia (UroToday.com) Dr. David Lin from Seattle, Washington, presented his second talk of the day on “Prostate Tissue Molecular Profiling: Which, When, and Why?”.

Atlanta, Georgia (UroToday.com) At the first in-person conference in urology since the COVID-19 pandemic shutdown happened in March 2020, Dr. David Lin from Seattle, Washington, was the first speaker after the welcome and introductions delivered by Drs. Herbert Lepor and Neal Shore. He presented on “Smarter Prostate Cancer Screening: Who to and Who Not to […]